Rare Pathogenic Variants in Mitochondrial and Inflammation-Associated Genes May Lead to Inflammatory Cardiomyopathy in Chagas Disease

[1]  H. Nakaya,et al.  miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy , 2020, PLoS neglected tropical diseases.

[2]  P. Wipf,et al.  ETHE1 and MOCS1 deficiencies: Disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts , 2019, Scientific Reports.

[3]  P. Matarrese,et al.  Inflammatory cytokines associated with cancer growth induce mitochondria and cytoskeleton alterations in cardiomyocytes , 2019, Journal of cellular physiology.

[4]  I. Blasig,et al.  Doxorubicin‐induced cardiotoxicity involves IFNγ‐mediated metabolic reprogramming in cardiomyocytes , 2019, The Journal of pathology.

[5]  S. Priori,et al.  Dilated cardiomyopathy , 1992, Nature reviews. Disease primers.

[6]  J. Kalil,et al.  Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy , 2018, Front. Immunol..

[7]  R. Tian,et al.  Mitochondrial dysfunction in pathophysiology of heart failure , 2018, The Journal of clinical investigation.

[8]  H. Tanowitz,et al.  Pathogenesis of Chronic Chagas Disease: Macrophages, Mitochondria, and Oxidative Stress , 2018, Current Clinical Microbiology Reports.

[9]  E. Bocchi,et al.  Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment. , 2017, Journal of the American College of Cardiology.

[10]  Christophe Béroud,et al.  Exome Sequencing Identifies Two Variants of the Alkylglycerol Monooxygenase Gene as a Cause of Relapses in Visceral Leishmaniasis in Children, in Sudan , 2017, The Journal of infectious diseases.

[11]  Steven B Marston,et al.  Obscurin variants and inherited cardiomyopathies , 2017, Biophysical Reviews.

[12]  J. Casanova,et al.  Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis. , 2017, Journal of the American College of Cardiology.

[13]  M. González-Gay,et al.  Leptin in the interplay of inflammation, metabolism and immune system disorders , 2017, Nature Reviews Rheumatology.

[14]  J. Finsterer,et al.  Therapeutic Advances in Gastroenterology , 2022 .

[15]  John G Doench,et al.  A Genome-wide CRISPR Death Screen Identifies Genes Essential for Oxidative Phosphorylation. , 2016, Cell metabolism.

[16]  A. Ribeiro,et al.  Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile , 2016, BMJ Open.

[17]  Y. Okazaki,et al.  A Comprehensive Genomic Analysis Reveals the Genetic Landscape of Mitochondrial Respiratory Chain Complex Deficiencies , 2016, PLoS genetics.

[18]  D. Lacroix,et al.  From cardiac mitochondrial dysfunction to clinical arrhythmias. , 2015, International journal of cardiology.

[19]  J. Finsterer,et al.  Cardiac manifestations of primary mitochondrial disorders. , 2014, International journal of cardiology.

[20]  E. Victor,et al.  Interferon-gamma induced cell death: Regulation and contributions of nitric oxide, cJun N-terminal kinase, reactive oxygen species and peroxynitrite. , 2014, Biochimica et biophysica acta.

[21]  M. Soares,et al.  Tissue damage control in disease tolerance. , 2014, Trends in immunology.

[22]  E. Bocchi,et al.  Myocardial Gene Expression of T-bet, GATA-3, Ror-γt, FoxP3, and Hallmark Cytokines in Chronic Chagas Disease Cardiomyopathy: An Essentially Unopposed TH1-Type Response , 2014, Mediators of inflammation.

[23]  A. Ribeiro,et al.  Electrocardiographic Abnormalities in Elderly Chagas Disease Patients: 10‐Year Follow‐Up of the Bambuí Cohort Study of Aging , 2014, Journal of the American Heart Association.

[24]  Paul H. Goldspink,et al.  Could interferon-gamma be a therapeutic target for treating heart failure? , 2014, Heart Failure Reviews.

[25]  T. Suuronen,et al.  Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. , 2013, Cellular signalling.

[26]  F. Lombardi,et al.  Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[27]  S. Ekker,et al.  Trapping Cardiac Recessive Mutants via Expression-Based Insertional Mutagenesis Screening , 2013, Circulation research.

[28]  T. Uchiumi,et al.  Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction , 2012, Bioscience reports.

[29]  B. Funke,et al.  Dilated cardiomyopathy , 2007, Archives of Disease in Childhood.

[30]  N. Garg,et al.  Defects of mtDNA Replication Impaired Mitochondrial Biogenesis During Trypanosoma cruzi Infection in Human Cardiomyocytes and Chagasic Patients: The Role of Nrf1/2 and Antioxidant Response , 2012, Journal of the American Heart Association.

[31]  B. Berk,et al.  G protein coupled receptor kinase 2 interacting protein 1 (GIT1) is a novel regulator of mitochondrial biogenesis in heart. , 2011, Journal of molecular and cellular cardiology.

[32]  N. Stolf,et al.  Selective Decrease of Components of the Creatine Kinase System and ATP Synthase Complex in Chronic Chagas Disease Cardiomyopathy , 2011, PLoS neglected tropical diseases.

[33]  B. Ianni,et al.  Avaliação do metabolismo dos fosfatos de alta energia em pacientes com doença de Chagas , 2010 .

[34]  R. Weiss,et al.  Evaluation of the metabolism of high energy phosphates in patients with Chagas' disease. , 2010, Arquivos brasileiros de cardiologia.

[35]  M. Fresno,et al.  IFN-γ-Induced TNF-α Expression Is Regulated by Interferon Regulatory Factors 1 and 8 in Mouse Macrophages1 , 2008, The Journal of Immunology.

[36]  M. Fresno,et al.  IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. , 2008, Journal of immunology.

[37]  S. I. Park,et al.  The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. , 2007, Journal of molecular biology.

[38]  P. Allen,et al.  Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. , 2005, The American journal of pathology.

[39]  C. Long,et al.  Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo , 2001, Pflügers Archiv.

[40]  C. Mady,et al.  Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. , 2001, Journal of autoimmunity.

[41]  D. Rabier,et al.  Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. , 1999, Circulation.

[42]  João Pimenta,et al.  Evolução clínica a longo prazo, correlacionando a presença de bloqueios da condução intraventricular em pacientes chagásicos e não chagásicos assintomáticos , 1999 .

[43]  J. Pimenta,et al.  [Long-term follow up of asymptomatic chagasic individuals with intraventricular conduction disturbances, correlating with non-chagasic patients]. , 1999, Revista da Sociedade Brasileira de Medicina Tropical.

[44]  R. Chuit,et al.  Risk of death due to chronic chagasic cardiopathy. , 1999, Memorias do Instituto Oswaldo Cruz.

[45]  H. Gonzalez,et al.  Echocardiographic and Clinical Predictors of Mortality in Chronic Chagas' Disease , 1998, Echocardiography.

[46]  F. Pileggi,et al.  Anin SituQuantitative Immunohistochemical Study of Cytokines and IL-2R+in Chronic Human Chagasic Myocarditis: Correlation with the Presence of MyocardialTrypanosoma cruziAntigens , 1997 .

[47]  G. Baroldi,et al.  Sudden and unexpected death in clinically 'silent' Chagas' disease. A hypothesis. , 1997, International journal of cardiology.

[48]  F. Pileggi,et al.  An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. , 1997, Clinical immunology and immunopathology.

[49]  J. Aliberti,et al.  Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages , 1995, Infection and immunity.

[50]  D. Dávila,et al.  Electrocardiographic abnormalities and left ventricular systolic function in Chagas' heart disease. , 1990, International journal of cardiology.

[51]  F. Pileggi,et al.  The Role of active myocarditis in the development of heart failure in chronic chagas' disease: A study based on endomyocardial biopsies , 1987, Clinical cardiology.

[52]  Miyazawa Shoko,et al.  Reduction of β-oxidation capacity of rat liver mitochondria by feeding orotic acid , 1982 .

[53]  T. Hashimoto,et al.  Reduction of beta-oxidation capacity of rat liver mitochondria by feeding orotic acid. , 1982, Biochimica et biophysica acta.